Table 1. Clinical characteristics of the 1,092 breast cancer patients from TCGA.
| Characteristic | TCGA BRCA (N = 1,092) |
|---|---|
| Age median (range) | 59 (26–90) |
| Sex | |
| Female | 1,080 (98.9%) |
| Male | 12 (1.1%) |
| Tumor stage | |
| T1 | 279 (25.5%) |
| T2 | 635 (58.2%) |
| T3 | 138 (12.6%) |
| T4 | 40 (3.7%) |
| Lymph node stage | |
| N (-) | 333 (30.5%) |
| N (+) | 759 (69.5%) |
| Metastasis stage | |
| M (-) | 903(82.7%) |
| M (+) | 189(17.3%) |
| TNM stage | |
| TNM I | 181 (16.5%) |
| TNM II | 637 (58.3%) |
| TNM III | 254 (23.3%) |
| TNM IV | 20 (18.3%) |
| Subtypes | |
| Luminal | 426 (39.0%) |
| Her2+_HR+ | 59 (5.4%) |
| Her2+_HR- | 30 (2.7%) |
| Tri-negative | 97 (8.9%) |
| Unknown | 480(44.0%) |
| Status | |
| Living | 940 (86.1%) |
| Decreased | 152 (13.9%) |